Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study.

MLA

de Andrade, Kelvin César, et al. “Cancer Incidence, Patterns, and Genotype-Phenotype Associations in Individuals with Pathogenic or Likely Pathogenic Germline TP53 Variants: An Observational Cohort Study.” The Lancet. Oncology, vol. 22, no. 12, Dec. 2021, pp. 1787–98. EBSCOhost, https://doi.org/10.1016/S1470-2045(21)00580-5.

APA

de Andrade, K. C., Khincha, P. P., Hatton, J. N., Frone, M. N., Wegman-Ostrosky, T., Mai, P. L., Best, A. F., & Savage, S. A. (2021). Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: an observational cohort study. The Lancet. Oncology, 22(12), 1787–1798. https://doi.org/10.1016/S1470-2045(21)00580-5

Chicago

de Andrade, Kelvin César, Payal P Khincha, Jessica N Hatton, Megan N Frone, Talia Wegman-Ostrosky, Phuong L Mai, Ana F Best, and Sharon A Savage. 2021. “Cancer Incidence, Patterns, and Genotype-Phenotype Associations in Individuals with Pathogenic or Likely Pathogenic Germline TP53 Variants: An Observational Cohort Study.” The Lancet. Oncology 22 (12): 1787–98. doi:10.1016/S1470-2045(21)00580-5.